Medicines labeled for the same conditions
Alternatives to ofatumumab
4 other medicines are given the same way (subcutaneous) and in the same FDA class as ofatumumab or labeled mainly for the same use (multiple sclerosis); the others include 2 interferon betas and 1 adrenocorticotropic hormone (FDA labels read October 8, 2026).
Which medicines are labeled for the same conditions as ofatumumab?
Multiple sclerosis lists all 23 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.
| Medicine and FDA class | Shared indication | Generic labelers (subcutaneous) | Pharmacy cost | Boxed warning | Shortage |
|---|---|---|---|---|---|
| Ofatumumabcd20-directed cytolytic antibody | this medicine | none listed | $24,369.37 per mL 20 mg/0.4 mL pen | No | No current entry |
| Glatiramer | Multiple sclerosis | 8 labelers | $86.10 per mL 40 mg/mL syringe | Yes | No current entry |
| Interferon beta 1ainterferon beta | Multiple sclerosis | none listed | $1,848.67 per mL 44 mcg/0.5 mL | No | No current entry |
| Peginterferon beta 1ainterferon beta | Multiple sclerosis | none listed | n/a | No | No current entry |
| Corticotropinadrenocorticotropic hormone | Multiple sclerosis | none listed | n/a | No | No current entry |
Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)
What do pharmacies pay for each?
The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What next?
- Ofatumumab: the full record
- label, generics, price, shortages, recalls